FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3864811000001106: Maprotiline 10mg tablets 30 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21759301000001115 Maprotiline 10mg tablets 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21759401000001111 Maprotiline 10mg tablets 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Maprotiline 10mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Maprotiline 10mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Maprotiline 10mg tablets 30 tablet Is pack of Product containing precisely maprotiline hydrochloride 10 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Maprotiline 10mg tablets 30 tablet Has active ingredient Maprotiline hydrochloride false Inferred relationship Existential restriction modifier
Maprotiline 10mg tablets 30 tablet Has active ingredient Maprotiline false Inferred relationship Existential restriction modifier
Maprotiline 10mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Maprotiline 10mg tablets 30 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Maprotiline 10mg tablets 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Maprotiline 10mg tablets 30 tablet Has VMP Product containing precisely maprotiline hydrochloride 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Maprotiline 10mg tablets 30 tablet Has specific active ingredient Maprotiline hydrochloride true Inferred relationship Existential restriction modifier
Maprotiline 10mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Ludiomil 10mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet 3 x 10 tablets Is a True Maprotiline 10mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start